Spin Off Growth McKesson's plan to spin off its Medical Surgical Solutions unit creates growth on two fronts. This opens up targeted sales to the parent and to the new independent company, offering IT modernization, care management solutions, and supply chain optimization services to both.

AI Commercialization The BranchLab AI investment signals appetite for AI in pharma commercialization. Position to offer AI powered market analytics, forecasting, and campaign optimization tools that integrate with McKesson's existing data and CRM stack.

Biotech Commercialization McKesson's engagement with Nanoscope Therapeutics demonstrates readiness to provide commercialization services to biotech firms. Opportunity to package services for other gene therapy and specialty biotech clients, including regulatory readiness and payer strategy.

Health IT Capabilities McKesson's tech stack indicates strong data tech capability and interoperability focus. Propose selling data integration, analytics, and cloud based supply chain and provider and payer optimization solutions to health systems, distributors, and manufacturers.

Scale Partnerships With a broad distribution footprint and significant healthcare market presence, there are opportunities to partner with large hospital systems and suppliers for end to end digital transformation, supply chain efficiency, and value based care support across the ecosystem.